Healthcare - Sector
OVID is currently covered by 6 analysts with an average price target of $5.25. This is a potential upside of $3.05 (138.64%) from yesterday's end of day stock price of $2.2.
Ovid Therapeutics's activity chart (see below) currently has 67 price targets and 72 ratings on display. The stock rating distribution of OVID is 100% BUY.
Analysts' price targets on this stock were met 10.81% of the time, taking 50.78 days on average.
Highest price target for OVID is $7, Lowest price target is $4, average price target is $5.25.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 11-Sep-2026. First documented stock forecast 30-May-2017.
Currently out of the existing stock ratings of OVID, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Apr-2024
$5
$2.8 (127.27%)
$4
2 months 10 days ago
(11-Sep-2026)
3/14 (21.43%)
$2.31 (85.87%)
178
Buy Since 09-Oct-2025
$5
$2.8 (127.27%)
$5
6 months 8 days ago
(13-May-2026)
0/3 (0%)
$2.2 (78.57%)
Buy Since 05-Apr-2024
$7
$4.45 (174.51%)
$7
7 months 6 days ago
(15-Apr-2026)
0/4 (0%)
$4.24 (153.62%)
Buy Since 16-Nov-2025
$5
$2.8 (127.27%)
$5
7 months 6 days ago
(15-Apr-2026)
0/2 (0%)
$2.24 (81.16%)
Buy Since 20-Dec-2023
$4
$1.8 (81.82%)
7 months 26 days ago
(26-Mar-2026)
0/5 (0%)
$1.54 (62.60%)
What is OVID (Ovid Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on OVID (Ovid Therapeutics)?
Which analyst has the most public recommendations on OVID (Ovid Therapeutics)?
Which analyst is the currently most bullish on OVID (Ovid Therapeutics)?
Which analyst is the currently most reserved on OVID (Ovid Therapeutics)?